Severe intestinal involvement in Wegener's granulomatosis.
Chow
Fiona Y F
FY
Hooke
David
D
Kerr
Peter G
PG
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D016099:Endoscopy, Gastrointestinal; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007413:Intestinal Mucosa / Q000473:pathology / Q000601:surgery; D007813:Laparotomy; D008297:Male; D008775:Methylprednisolone; D008875:Middle Aged; D010437:Peptic Ulcer / Q000175:diagnosis / Q000628:therapy; D011183:Postoperative Complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006435:Renal Dialysis; D012086:Reoperation; D012720:Severity of Illness Index
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone